AIRLINK 61.75 Decreased By ▼ -0.73 (-1.17%)
BOP 5.34 Decreased By ▼ -0.02 (-0.37%)
CNERGY 4.53 Decreased By ▼ -0.05 (-1.09%)
DFML 15.30 Decreased By ▼ -0.20 (-1.29%)
DGKC 65.57 Decreased By ▼ -0.83 (-1.25%)
FCCL 17.26 Decreased By ▼ -0.33 (-1.88%)
FFBL 27.63 Decreased By ▼ -0.07 (-0.25%)
FFL 9.27 No Change ▼ 0.00 (0%)
GGL 10.00 Decreased By ▼ -0.06 (-0.6%)
HBL 104.89 Decreased By ▼ -0.81 (-0.77%)
HUBC 121.45 Decreased By ▼ -0.85 (-0.7%)
HUMNL 6.50 Decreased By ▼ -0.10 (-1.52%)
KEL 4.46 Decreased By ▼ -0.04 (-0.89%)
KOSM 4.37 Decreased By ▼ -0.11 (-2.46%)
MLCF 35.77 Decreased By ▼ -0.43 (-1.19%)
OGDC 122.41 Decreased By ▼ -0.51 (-0.41%)
PAEL 22.75 Decreased By ▼ -0.25 (-1.09%)
PIAA 30.94 Increased By ▲ 1.60 (5.45%)
PIBTL 5.82 Increased By ▲ 0.02 (0.34%)
PPL 107.30 Decreased By ▼ -0.20 (-0.19%)
PRL 27.30 Increased By ▲ 0.05 (0.18%)
PTC 17.45 Decreased By ▼ -0.62 (-3.43%)
SEARL 52.95 Decreased By ▼ -0.05 (-0.09%)
SNGP 62.81 Decreased By ▼ -0.40 (-0.63%)
SSGC 10.70 Decreased By ▼ -0.10 (-0.93%)
TELE 9.06 Decreased By ▼ -0.14 (-1.52%)
TPLP 11.53 Increased By ▲ 0.09 (0.79%)
TRG 70.35 Decreased By ▼ -0.51 (-0.72%)
UNITY 23.59 Decreased By ▼ -0.03 (-0.13%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
BR100 6,929 Decreased By -14.4 (-0.21%)
BR30 22,692 Decreased By -135.5 (-0.59%)
KSE100 67,037 Decreased By -104.7 (-0.16%)
KSE30 22,055 Decreased By -35.1 (-0.16%)
World

South Africa asks India's Serum Institute to take back one million COVID vaccine doses due to limited effectiveness

  • South African authorities suspended the use of the shot after preliminary studies suggested limited effectiveness against the more contagious local variant of the virus
  • Serum Institute of India had supplied one million doses of the COVID-19 vaccine to South Africa last week while another 500,000 doses were due to arrive in the next few weeks
Published February 16, 2021

(Karachi) In a major setback to India, South Africa has asked India's Serum Institute to take back the one million COVID-19 vaccine doses the company had sent in early February, Forbes reported on Tuesday.

The decision comes a week after the South Africa said it will put on hold use of AstraZeneca's shot in its vaccination program. South African authorities suspended the use of the shot after preliminary studies suggested limited effectiveness against the more contagious local variant of the virus.

As per the report, Serum Institute of India, which is producing AstraZeneca's shot, had supplied one million doses of the COVID-19 vaccine to South Africa last week while another 500,000 doses were due to arrive in the next few weeks.

South Africa’s health minister has said the government may sell doses of AstraZeneca’s vaccine, after the country paused its roll-out following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.

The African country, which is yet to launch its COVID-19 vaccination program, has decided to start vaccinating health workers with Johnson & Johnson’s vaccine in the form of an “implementation study” with researchers.

Comments

Comments are closed.